↓ Skip to main content

Cochrane Database of Systematic Reviews

Cannabinoids for epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, March 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Citations

dimensions_citation
160 Dimensions

Readers on

mendeley
535 Mendeley
Title
Cannabinoids for epilepsy
Published in
Cochrane database of systematic reviews, March 2014
DOI 10.1002/14651858.cd009270.pub3
Pubmed ID
Authors

David Gloss, Barbara Vickrey

Abstract

Marijuana appears to have anti-epileptic effects in animals. It is not currently known if it is effective in patients with epilepsy. Some states in the United States of America have explicitly approved its use for epilepsy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 535 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 <1%
United Kingdom 2 <1%
Brazil 1 <1%
Puerto Rico 1 <1%
Peru 1 <1%
Unknown 525 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 108 20%
Student > Master 69 13%
Researcher 67 13%
Other 45 8%
Student > Ph. D. Student 40 7%
Other 91 17%
Unknown 115 21%
Readers by discipline Count As %
Medicine and Dentistry 153 29%
Pharmacology, Toxicology and Pharmaceutical Science 46 9%
Agricultural and Biological Sciences 36 7%
Neuroscience 35 7%
Psychology 33 6%
Other 96 18%
Unknown 136 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 148. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2024.
All research outputs
#290,978
of 26,199,717 outputs
Outputs from Cochrane database of systematic reviews
#469
of 13,194 outputs
Outputs of similar age
#2,309
of 236,586 outputs
Outputs of similar age from Cochrane database of systematic reviews
#9
of 240 outputs
Altmetric has tracked 26,199,717 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,194 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,586 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 240 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.